Company Description

Alivexis, formerly Modulus Discovery, is a technology-driven drug discovery company creating small-molecule therapeutics through advanced molecular simulation and AI. Their proprietary ModBind platform enables high-speed, high-accuracy prediction of absolute protein–ligand binding free energy, supporting rapid hit identification, lead optimization, and candidate selection across diverse targets.